Hairy cell leukemia

Francis Joseph Giles

Hairy cell leukemia

Francis Joseph Giles

Medicine

Research output: Other contribution (Published) › Other contribution

Abstract

Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with hairy lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.

Original language	English (Ireland)
Media of output	Reviews
Volume	24
Publication status	Published - 1 Jul 2007

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@misc{d2fcd3edd859445c8ad2cdd2df0fadb3,

title = "Hairy cell leukemia",

abstract = "Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with hairy lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.",

author = "Giles, \{Francis Joseph\}",

year = "2007",

month = jul,

day = "1",

language = "English (Ireland)",

volume = "24",

type = "Other",

}

TY - GEN

T1 - Hairy cell leukemia

AU - Giles, Francis Joseph

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with hairy lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.

AB - Hairy cell leukemia (HCL) is a chronic B-cell lymphoproliferative disorder characterized by pancytopenia and variable infiltration of the reticuloendothelial system with hairy lymphocytes. HCL is more common in men than women and has a median age of diagnosis of 52 yr. Typically, patients with HCL respond well to purine analog-based therapy. The purpose of this review will be to establish the current status of HCL with respect to its pathophysiology, diagnosis, management, and future directions.

M3 - Other contribution

VL - 24

ER -

Hairy cell leukemia

Abstract

UN SDGs

Fingerprint

Cite this